SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
CARA
--
0.00%
--
Top Marijuana Stocks on the NASDAQ for June 2020
Investopedia · 05/28 16:38
Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference
STAMFORD, Conn., May 27, 2020 -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to.
GlobeNewswire · 05/27 20:01
Cantor Fitzgerald Reiterates Overweight on Cara Therapeutics, Raises Price Target to $40
Cantor Fitzgerald reiterates Cara Therapeutics (NASDAQ:CARA) with a Overweight and raises the price target from $34 to $40.
Benzinga · 05/19 11:27
Is Cara Therapeutics (CARA) Stock a Solid Choice Right Now?
Zacks · 05/15 16:00
Edited Transcript of CARA earnings conference call or presentation 11-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/12 10:00
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/12 05:06
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
Zacks · 05/11 22:55
Cara Therapeutics Reports First Quarter 2020 Financial Results
GlobeNewswire · 05/11 21:01
Cara Therapeutics Q1 EPS $(0.620), Inline, Sales $8.093M Beat $4.760M Estimate
Cara Therapeutics (NASDAQ:CARA) reported quarterly losses of $(0.620) per share which met the analyst consensus estimate. This is a 10.71 percent decrease over losses of $(0.560) per share from the same period last year.
Benzinga · 05/11 20:06
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference
STAMFORD, Conn., May 07, 2020 -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to.
GlobeNewswire · 05/07 11:00
Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11, 2020
STAMFORD, Conn., May 04, 2020 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to.
GlobeNewswire · 05/04 20:01
Will Cara Therapeutics (NASDAQ:CARA) Spend Its Cash Wisely?
Simply Wall St. · 04/29 12:03
Better Buy: Cara Therapeutics vs. Sangamo Therapeutics
MotleyFool.com · 04/29 11:14
Earnings Preview: Cara Therapeutics (CARA) Q1 Earnings Expected to Decline
Zacks · 04/28 17:34
10 Biggest Price Target Changes For Wednesday
Rosenblatt lowered Texas Instruments Incorporated (NASDAQ: TXN) price target from $150 to $135. Texas Instruments closed at $106.84 on Tuesday.
Benzinga · 04/22 12:08
Cantor Fitzgerald Reiterates Overweight on Cara Therapeutics, Raises Price Target to $34
Cantor Fitzgerald analyst Charles Duncan reiterates Cara Therapeutics (NASDAQ:CARA) with a Overweight and raises the price target from $26 to $34.
Benzinga · 04/22 10:39
Cara Therapeutics Reports Success for Korsuva in Pivotal Trial
MotleyFool.com · 04/21 22:03
BYND, OPK among premarket gainers
Seeking Alpha - Article · 04/21 13:16
Cara Therapeutics' Shares March Higher, Can It Continue?
Zacks · 04/21 13:07